Injective sits further down the market cap rankings at #106, which weighs on the fundamentals score relative to more dominant names in the DeFi category. On-chain health is measured on fee revenue, value secured, turnover: $0.0M in fees over 24h (0.6% annualised against market cap), and $8.4M of value secured (2% of market cap), and 24h volume at 10.3% of market cap. That compares favourably against the rest of the rated universe.
Momentum has cooled, with price down -6.0% over the trailing 7 days. The risk pillar is holding up reasonably well, with 24h price action of -1.8% that doesn't suggest acute stress.
The composite grade of C puts Injective at the 39th percentile of the rated universe on a weighted blend of fundamentals (35%), on-chain health (25%), momentum (20%), and inverted risk (20%). See the Methodology page for how each pillar is defined.
Every Antelux grade is mechanical: no analyst overrides. Each pillar below shows the exact measured input, and its score is a percentile rank against the other rated coins on that measure, so 90 means it beats 90% of the universe rather than scoring 90 out of 100. Full methodology, weightings, and grade bands are on the Methodology page.
Blends market standing with tokenomics. Rank #106 caps the sub-score; with no supply cap, emission policy is scored neutrally with a slight caution.
Antelux began recording daily scores on 2026-08-15. History cannot be back-filled, so this chart fills in from that day forward. Check back in a week.